{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:08:50Z","timestamp":1790856530880,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omta.2026.201806","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:44:00Z","timestamp":1783640640000},"page":"201806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["AI-engineered AAV capsid enables intravitreal delivery for the treatment of diverse retinal degenerations"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0173-9045","authenticated-orcid":false,"given":"Mochen","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenguang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Wekselblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2748-4572","authenticated-orcid":false,"given":"Sheng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201806_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/iovs.66.6.19","article-title":"Expansion of the ABCA4-Associated Retinopathy Spectrum: Severe Variants Can be Associated With Early-Onset Severe Retinal Dystrophy","volume":"66","author":"Panneman","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201806_bib2","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.omta.2026.201806_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","article-title":"Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial","volume":"388","author":"Bennett","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.omta.2026.201806_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/mt.2010.40","article-title":"AAV vectors avoid inflammatory signals necessary to render transduced hepatocyte targets for destructive T cells","volume":"18","author":"Somanathan","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201806_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108637","article-title":"Novel variants in GUCY2D causing retinopathy and the genotype-phenotype correlation","volume":"208","author":"Yi","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omta.2026.201806_bib6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/bjophthalmol-2016-309975","article-title":"Leber congenital amaurosis\/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions","volume":"101","author":"Kumaran","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.omta.2026.201806_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.omtm.2022.12.007","article-title":"Preclinical studies in support of phase I\/II clinical trials to treat GUCY2D-associated Leber congenital amaurosis","volume":"28","author":"Boye","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201806_bib8","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2165\/00003495-200767080-00007","article-title":"Ranibizumab","volume":"67","author":"Blick","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.omta.2026.201806_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13554-012-0003-4","article-title":"Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases","volume":"2","author":"Sophie","year":"2012","journal-title":"Biol. Ther."},{"key":"10.1016\/j.omta.2026.201806_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrd.2015.17","article-title":"Ten years of anti-vascular endothelial growth factor therapy","volume":"15","author":"Ferrara","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omta.2026.201806_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/mef2.33","article-title":"Antiangiogenic therapy for ocular diseases: Current status and challenges","volume":"2","author":"Chen","year":"2023","journal-title":"MedComm\u2013Future Medicine"},{"key":"10.1016\/j.omta.2026.201806_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ebiom.2016.11.016","article-title":"Phase 2a randomized clinical trial: safety and post hoc analysis of subretinal rAAV. sFLT-1 for wet age-related macular degeneration","volume":"14","author":"Constable","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omta.2026.201806_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40259-023-00629-y","article-title":"AAV-based strategies for treatment of retinal and choroidal vascular diseases: advances in age-related macular degeneration and diabetic retinopathy therapies","volume":"38","author":"Castro","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.omta.2026.201806_bib14","series-title":"Oral Presentation at: American Academy of Ophthalmology. October 1","article-title":"Gene Therapy for Neovascular AMD: Subretinal RGX-314: Phase I\/IIa Long-Term Follow-Up Results up to 4 Years","author":"Campochiaro","year":"2022"},{"key":"10.1016\/j.omta.2026.201806_bib15","first-page":"2023","article-title":"Subretinal delivery of investigational ABBV-RGX-314 for neovascular AMD: a phase II pharmacodynamic study","volume":"30","author":"Abbey","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201806_bib16","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0140-6736(24)01447-8","article-title":"Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1\/2, multicentre, open-label, unilateral dose escalation study","volume":"404","author":"Yang","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.omta.2026.201806_bib17","first-page":"1152","article-title":"Suprachoroidal Delivery of Investigational ABBV-RGX-314 for Diabetic Retinopathy: The Phase II ALTITUDE\u00ae Study","volume":"63","author":"Dhoot","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201806_bib18","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.3390\/jcm11164717","article-title":"Subretinal injection techniques for retinal disease: a review","volume":"11","author":"Irigoyen","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.omta.2026.201806_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omta.2026.201806_bib20","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41592-022-01547-7","article-title":"Directed evolution of adeno-associated virus for efficient gene delivery to microglia","volume":"19","author":"Lin","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201806_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005708","article-title":"In vivo\u2013directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2026.201806_bib22","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1038\/s41467-024-48221-4","article-title":"An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species","volume":"15","author":"Luo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201806_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41587-020-00793-4","article-title":"Deep diversification of an AAV capsid protein by machine learning","volume":"39","author":"Bryant","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201806_bib24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.aaw2900","article-title":"Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design","volume":"366","author":"Ogden","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.omta.2026.201806_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.tibs.2024.03.002","article-title":"Computationally guided AAV engineering for enhanced gene delivery","volume":"49","author":"Guo","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.omta.2026.201806_bib26","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.1038\/s41467-024-52002-4","article-title":"An engineered AAV targeting integrin alpha V beta 6 presents improved myotropism across species","volume":"15","author":"Vu Hong","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201806_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002112","article-title":"Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood-brain barrier","volume":"21","author":"Huang","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.omta.2026.201806_bib28","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1038\/s41467-024-50555-y","article-title":"Systematic multi-trait AAV capsid engineering for efficient gene delivery","volume":"15","author":"Eid","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201806_bib29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.omtm.2020.11.017","article-title":"Applying machine learning to predict viral assembly for adeno-associated virus capsid libraries","volume":"20","author":"Marques","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201806_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12859-024-05823-5","article-title":"Unsupervised modeling of mutational landscapes of adeno-associated viruses viability","volume":"25","author":"De Leonardis","year":"2024","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.omta.2026.201806_bib31","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.32733","article-title":"Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapy","volume":"77","author":"Meumann","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.omta.2026.201806_bib32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jsb.2008.12.002","article-title":"Heparin binding induces conformational changes in Adeno-associated virus serotype 2","volume":"165","author":"Levy","year":"2009","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.omta.2026.201806_bib33","doi-asserted-by":"crossref","first-page":"11072","DOI":"10.1128\/JVI.77.20.11072-11081.2003","article-title":"Identification of a heparin-binding motif on adeno-associated virus type 2 capsids","volume":"77","author":"Kern","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201806_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40259-023-00585-7","article-title":"Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer","volume":"37","author":"Arjomandnejad","year":"2023","journal-title":"BioDrugs"},{"key":"10.1016\/j.omta.2026.201806_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49112-2","article-title":"AAV capsid bioengineering in primary human retina models","volume":"13","author":"Westhaus","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201806_bib36","doi-asserted-by":"crossref","first-page":"8837","DOI":"10.1074\/jbc.M610369200","article-title":"The Function of Guanylate Cyclase 1 and Guanylate Cyclase 2 in Rod and Cone Photoreceptors","volume":"282","author":"Baehr","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201806_bib37","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1167\/iovs.07-0257","article-title":"AAV-mediated expression targeting of rod and cone photoreceptors with a human rhodopsin kinase promoter","volume":"48","author":"Khani","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201806_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/tvst.11.4.3","article-title":"Tropism of AAV Vectors in Photoreceptor-Like Cells of Human iPSC-Derived Retinal Organoids","volume":"11","author":"McClements","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.omta.2026.201806_bib39","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1089\/hum.2012.125","article-title":"The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retina","volume":"23","author":"Boye","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201806_bib40","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/hmg\/ddt609","article-title":"The transcription-splicing protein NonO\/p54nrb and three NonO-interacting proteins bind to distal enhancer region and augment rhodopsin expression","volume":"23","author":"Yadav","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omta.2026.201806_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0896-6273(91)90355-4","article-title":"Unusual topography of bovine rhodopsin promoter-IacZ fusion gene expression in transgenic mouse retinas","volume":"6","author":"Zack","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.omta.2026.201806_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/jop.2014.0125","article-title":"Functional Characterization of AAV-Expressed Recombinant Anti-VEGF Single-Chain Variable Fragments In Vitro","volume":"31","author":"Wimmer","year":"2015","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.omta.2026.201806_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102394","article-title":"Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study","volume":"67","author":"Khanani","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.omta.2026.201806_bib44","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1128\/JVI.80.2.821-834.2006","article-title":"Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization","volume":"80","author":"Lochrie","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201806_bib45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.virol.2008.11.037","article-title":"Adeno-associated virus-2 and its primary cellular receptor\u2014Cryo-EM structure of a heparin complex","volume":"385","author":"O'Donnell","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.omta.2026.201806_bib46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41434-022-00380-z","article-title":"Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters","volume":"30","author":"Nieuwenhuis","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201806_bib47","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1101\/gr.241653.118","article-title":"CG dinucleotides enhance promoter activity independent of DNA methylation","volume":"29","author":"Hartl","year":"2019","journal-title":"Genome Res."},{"key":"10.1016\/j.omta.2026.201806_bib48","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1021\/acssynbio.3c00078","article-title":"Tuning Methylation-Dependent Silencing Dynamics by Synthetic Modulation of CpG Density","volume":"12","author":"Ma","year":"2023","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.omta.2026.201806_bib49","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cels.2022.11.005","article-title":"The sound of silence: Transgene silencing in mammalian cell engineering","volume":"13","author":"Cabrera","year":"2022","journal-title":"Cell Syst."},{"key":"10.1016\/j.omta.2026.201806_bib50","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.3390\/v5102561","article-title":"Inhibition of histone deacetylation and DNA methylation improves gene expression mediated by the adeno-associated virus\/phage in cancer cells","volume":"5","author":"Kia","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.omta.2026.201806_bib51","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/mt.2012.46","article-title":"Extensive Methylation of Promoter Sequences Silences Lentiviral Transgene Expression During Stem Cell Differentiation In Vivo","volume":"20","author":"Herbst","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201806_bib52","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ymben.2021.04.014","article-title":"Enhanced targeted DNA methylation of the CMV and endogenous promoters with dCas9-DNMT3A3L entails distinct subsequent histone modification changes in CHO cells","volume":"66","author":"Marx","year":"2021","journal-title":"Metab. Eng."},{"key":"10.1016\/j.omta.2026.201806_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.omtm.2018.01.004","article-title":"Target-Cell-Directed Bioengineering Approaches for Gene Therapy of Hemophilia A","volume":"9","author":"Brown","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201806_bib54","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s44321-024-00037-x","article-title":"Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor","volume":"16","author":"Xie","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omta.2026.201806_bib55","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ophtha.2019.03.023","article-title":"Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial","volume":"126","author":"Sahni","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omta.2026.201806_bib57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(17)30979-0","article-title":"Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial","volume":"390","author":"Heier","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.omta.2026.201806_bib58","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ebiom.2016.11.016","article-title":"Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration","volume":"14","author":"Constable","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omta.2026.201806_bib59","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.omta.2026.201806_bib60","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-connectivity fingerprints","volume":"50","author":"Rogers","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.omta.2026.201806_bib61","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1109\/4235.996017","article-title":"A fast and elitist multiobjective genetic algorithm: NSGA-II","volume":"6","author":"Deb","year":"2002","journal-title":"IEEE Trans. Evol. Comput."},{"key":"10.1016\/j.omta.2026.201806_bib62","first-page":"2171","article-title":"DEAP: evolutionary algorithms made easy","volume":"13","author":"Fortin","year":"2012","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.omta.2026.201806_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.omta.2026.201806_bib64","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","article-title":"Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets","volume":"161","author":"Macosko","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201806_bib65","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cell.2019.01.004","article-title":"Molecular Classification and Comparative Taxonomics of Foveal and Peripheral Cells in Primate Retina","volume":"176","author":"Peng","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201806_bib66","doi-asserted-by":"crossref","first-page":"D721","DOI":"10.1093\/nar\/gky900","article-title":"CellMarker: a manually curated resource of cell markers in human and mouse","volume":"47","author":"Zhang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omta.2026.201806_bib67","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/gt.2013.64","article-title":"Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach","volume":"21","author":"Mowat","year":"2014","journal-title":"Gene Ther."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:17:48Z","timestamp":1789053468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3117387X26001412"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201806","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-engineered AAV capsid enables intravitreal delivery for the treatment of diverse retinal degenerations","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201806"}}